This report presents the findings from the 2019–20 National Drug and Alcohol Survey (NDAS) on the prevalence of gambling and problem gambling in the general population in Ireland. While the main objective of the 2019–20 NDAS was to determine the prevalence and patterns of drug use (including alcohol and tobacco use), a set of questions on gambling in Ireland […]
This publication contains the 2020 corporate governance and financial statements of the Health Research Board, which have been approved by the Office of the Comptroller and Auditor General. Part one is also available for download (below), and contains a Chairperson and Chief Executive’s report; a timeline of the HRB’s key initiatives in response to the COVID-19 pandemic during […]
This report presents a snapshot of the outputs, outcomes, and some emerging impacts arising from 170 Health Research Board (HRB) awards (with a combined value of €49.5 million) that completed in 2018 and 2019. Further outputs, outcomes, and impacts can be expected to occur in the years following the completion of these awards. The outputs […]
This year’s Health Research in Action highlights some of the many notable impacts and outcomes of the Health Research Board’s work during 2020 across health and social care in Ireland, all of which made a real difference to people’s health, the health system, society, and economy.
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
This systematic review of randomized controlled trials (RCTs) evaluated the efficacy and safety of electronic cigarettes (e-cigarettes, ENDS) in helping people who smoke to achieve abstinence compared with electronic non-nicotine delivery systems (ENNDS, no nicotine) or any smoking cessation comparator treatment or combination of treatments at 24-26 weeks and at 52 weeks.
Contents include: Chairperson and Chief Executive’s report; a timeline of the HRB’s key initiatives in response to the COVID-19 pandemic in 2020: a snapshot of other important HRB activities during 2020; key deliverables in line with the HRB strategy 2016-2020; and Appendices. Part 2 contains the corporate governance and financial statements which have been approved by […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
Many different reimbursement systems exist for providers offering healthcare to service users in their homes or residential settings. Under case mix classification systems, service users are sorted into “care bands”, which group together service users with similar levels of care needs. Funding and resources are then allocated to providers based on the care bands of […]
Reablement services help older people accommodate illness or disability by helping them to learn or re-learn skills necessary for daily living. They are typically provided for a period of 6-12 weeks, and during this period they seek to enable older people to be as independent as possible in their day-to-day lives. The provision of reablement […]
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem drug use (excluding alcohol) in Ireland. It covers the period 2014 to 2020. In this seven-year period, 68,571 cases were treated for drug use as a main problem.
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem alcohol use in Ireland. It covers the period 2014 to 2020. In this seven-year period, 51,205 cases were treated for alcohol as a main problem drug.
The 2020 report provides data presented nationally as well as: * CHO * county * hospital type * individual psychiatric units/hospitals
The National Drug and Alcohol Survey (NDAS) collects information on alcohol and tobacco consumption, and drug use among the general population in Ireland. The extent and pattern of drug use in the general population is one of the five key indicators developed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and adopted […]
This systematic review of prospective longitudinal primary studies sought to determine whether electronic cigarette (e-cigarette) use by teenagers who had never smoked conventional tobacco cigarettes (tobacco cigarettes) at baseline was associated with subsequently commencing tobacco cigarette smoking.
This report provides: A profile of the 36,649 people with a disability reviewed on NASS in 2020; Details of the HSE disability-funded services currently availed of, and those required now or within the next five years. Supplementary reports on service users with an intellectual disability, physical or sensory disability and autism can be found below, along […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
Data were obtained on nearly 20,000 Irish children and adults living in various family care arrangements in 2007, 2012, and 2017. Over 10 years, the percentage increase in adult persons living with family carers was three times higher than the rise in the general population, with people aged 50 years and over having the highest […]
Although half of the world’s population does not drink, alcohol use is the seventh leading risk factor for both deaths and disability-adjusted life years globally, and the leading risk factor among those aged 15–49 years. Alcohol is a modifiable risk factor; reductions in alcohol consumption would lead to an associated reduction in the burden of […]
People who are homeless have complex and challenging lives. They tend to have worse physical and mental health, and are more likely to report problem substance use, than the general population. Substance use is more prevalent among people who are homeless than in the general population, and providing support services and drug treatment in a […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
Housing with support is purpose-built, non-institutional accommodation where older people have their own front door and where support or care services are available. The implementation of housing with support for older people is rapidly expanding, particularly as life expectancy is increasing throughout the world. This expansion is likely to intensify in the context of coronavirus […]
The HRB Strategy 2021–2025, Health research – making an impact, is a five-year strategic plan that defines the aims, activities and outcomes of the organisation at a high level. Developed following a process of extensive engagement with stakeholders, together with input from an International Expert Advisory Panel, the strategy sets out a clear direction for the HRB […]
This summary publication gives a rapid overview of the HRB Strategy 2021–2025, Health research – making an impact: the HRB’s five-year strategic plan that defines the aims, activities and outcomes of the organisation at a high level. Developed following a process of extensive engagement with stakeholders, together with input from an International Expert Advisory Panel, the strategy sets out […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
